Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest

Sponsor
Radboud University Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00441753
Collaborator
(none)
10
1

Study Details

Study Description

Brief Summary

Survivors of a cardiac arrest frequently develop severe postanoxic encephalopathy. Derangements in cerebral blood after return of spontaneous circulation play an important role in the pathogenesis of postanoxic encephalopathy. In the present study we examine the effect of mild therapeutic hypothermia on cerebral blood flow and carbondioxide reactivity in patients after cardiac arrest.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
    Study Start Date :
    Sep 1, 2006

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 95 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • adult patients

      • GCS after return of circulation < 7

      • Induced mild hypothermia for 24 hours

      • primary rhythm ventricular fibrillation

      Exclusion Criteria:
      • Thrombolysis

      • Cardiogenic shock with expected survival < 24 hrs

      • Pregnancy

      • No informed consent

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Radboud University Nijmegen Medical Centre Nijmegen Netherlands 6500 HB

      Sponsors and Collaborators

      • Radboud University Medical Center

      Investigators

      • Principal Investigator: Cornelia Hoedemaekers, MD PhD, Radboud University Medical Center
      • Study Director: Johannes van der Hoeven, MD PhD, Radboud University Medical Center

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00441753
      Other Study ID Numbers:
      • KSCH0601
      First Posted:
      Mar 1, 2007
      Last Update Posted:
      Feb 6, 2009
      Last Verified:
      Feb 1, 2009
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 6, 2009